Evidence map›Paper›PMID 39020029›Full record

ArticleAesthetic plastic surgery2025

Reduction Mammoplasties: Risk Factors and Early Complications-About 1442 Cases.

David Boccara, Marc Chaouat, Maurice Mimoun, Jeremy Kaplan, Kevin Serror, Claire Couteau

Abstract read
PubMed Publisher
In one paragraph

Article in Aesthetic plastic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

David BoccaraPlastic, Reconstructive and Cosmetic and Burn Surgery Unit, Hôpital Saint Louis, 1 Avenue Vellefaux, 75010, Paris, France. davboc9@hotmail.com.
Marc ChaouatPlastic, Reconstructive and Cosmetic and Burn Surgery Unit, Hôpital Saint Louis, 1 Avenue Vellefaux, 75010, Paris, France.
Maurice MimounPlastic, Reconstructive and Cosmetic and Burn Surgery Unit, Hôpital Saint Louis, 1 Avenue Vellefaux, 75010, Paris, France.
Jeremy KaplanDivision of Gastroenterology, Kingman Regional Medical Center, Kingman, AZ, USA.
Kevin SerrorPlastic, Reconstructive and Cosmetic and Burn Surgery Unit, Hôpital Saint Louis, 1 Avenue Vellefaux, 75010, Paris, France.
Claire CouteauPlastic, Reconstructive and Cosmetic and Burn Surgery Unit, Hôpital Saint Louis, 1 Avenue Vellefaux, 75010, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast reduction surgery is a widely performed plastic surgery procedure. The incidence of such complications has been steadily decreasing in recent years but is still nonetheless 5.6%. The primary aim of this study was to analyze the incidence of the main postoperative complications of breast reduction surgery. In addition, we identified cause-and-effect links between complications and characteristics of the patients, such as smoking, age, weight resection, BMI, and wound drainage. MATERIALS AND

methodsThis retrospective study was performed on a population of 1442 women who underwent breast reduction surgery between January 2016 and October 2022 in the plastic surgery unit at Saint-Louis Hospital, Paris, France. At the follow-up examination, we evaluated the patients for complications.

resultsThe average resection weight was 1297.7 g in a population for which the average BMI was 28.9. We found 19.9% rate of total complications, of which 3.5% were major complications. We found that only the resection weight was a risk factor for complications. DISCUSSION: The main strength of our study is the size of our sample. The large number of patients allowed us to conduct numerous analyses and obtain significant results despite the rarity of certain events. This large cohort was also responsible for the high statistical power of our results.

conclusionThe risk of developing a postoperative infection was 7.5% for resections of less than 2.4 kg, increasing to 13.9 % when greater than that. Thus, the administration of prophylactic antibiotic therapy to affected women to reduce the risk of infection is a distinct consideration. For the other factors, while none of them appeared to promote the occurrence of adverse events and, therefore, do not formally contraindicate breast reduction surgery, some preventive measures still strike us as being relevant, such as blade drainage, weight loss, diabetes control, and smoking cessation. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Indexed as

MammaplastyPostoperative ComplicationsAdultBody Mass IndexCohort StudiesFemaleFollow-Up StudiesFranceHumansIncidenceMiddle AgedRetrospective StudiesRisk AssessmentRisk FactorsTreatment OutcomeYoung AdultBreast reductionComplicationMammoplastyProphylactic antibiotic

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.